Search results
Feb 15, 2024 · This article will discuss eight current Food and Drug Administration (FDA)–approved weight loss drugs on the market.
FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
The FDA approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition, for use in addition to a...
Nov 8, 2023 · The Food and Drug Administration on Wednesday approved an obesity drug from the company Eli Lilly that will be a direct competitor to the wildly popular Wegovy. The drug is called tirzepatide...
The U.S. Food and Drug Administration (FDA) has approved four weight management medications for children ages 12 and older: orlistat (Xenical), 2 liraglutide (Saxenda), 3 phentermine-topiramate (Qsymia), 4 and semaglutide (Wegovy). 5,6 A fifth prescription medication, setmelanotide (IMCIVREE), 7 is approved by the FDA for children ages 6 years ...
Nov 8, 2023 · The FDA has approved Zepbound, an injectable weight loss drug from Eli Lilly that helped people lose up to 52 lbs in 16 months during clinical trials.
Mar 25, 2024 · In 2012, Qsymia (phentermine and extended-release topiramate) and Belviq (lorcaserin), two oral prescription medicines, were the first weight loss drugs approved in over a decade. However, Belviq was withdrawn from the market in 2020 due to safety concerns over a risk of cancer.
